23657982|t|Edaravone prevents neurotoxicity of mutant L166P DJ-1 in Parkinson's disease.
23657982|a|Parkinson's disease (PD), which is estimated to affect approximately 1 % of the population over the age of 65, is the second most common neurodegenerative disorder after Alzheimer's disease. It was reported that pathogenic mutations in DJ-1 lead to autosomal recessive early-onset familial Parkinsonism. The L166P mutant of DJ-1 is the most commonly studied loss-of-function mutation in early onset familial PD, but the underlying mechanisms are still unknown. Edaravone is a powerful free radical scavenger used in clinical treatment for cerebral ischemic stroke. In the present study, we investigated the effects of edaravone on the neurotoxicity in PD-induced isoforms of DJ-1 containing the mutation L166P. Our results indicated that edaravone was able to significantly attenuate oxidative stress and improve mitochondrial function. Furthermore, edaravone was found to reduce apoptosis in Neuro2a cells through modulation of mitochondria-dependent apoptosis pathways. Interestingly, our result also demonstrated that edaravone was able to up-regulate VMAT2 expression in N2a cells in a dose-dependent manner. Our findings enhance the understanding of the neuro-protective effects of edaravone in cell models and suggest that edaravone offers significant protection in a PD-related in vitro model.
23657982	0	9	Edaravone	Chemical	MESH:D000077553
23657982	19	32	neurotoxicity	Disease	MESH:D020258
23657982	43	48	L166P	ProteinMutation	tmVar:p|SUB|L|166|P;HGVS:p.L166P;VariantGroup:0;OriginalGene:57320;CorrespondingGene:11315;RS#:28938172;CorrespondingSpecies:10090;CA#:254090
23657982	49	53	DJ-1	Gene	57320
23657982	57	76	Parkinson's disease	Disease	MESH:D010300
23657982	78	97	Parkinson's disease	Disease	MESH:D010300
23657982	99	101	PD	Disease	MESH:D010300
23657982	215	241	neurodegenerative disorder	Disease	MESH:D019636
23657982	248	267	Alzheimer's disease	Disease	MESH:D000544
23657982	314	318	DJ-1	Gene	57320
23657982	368	380	Parkinsonism	Disease	MESH:D010302
23657982	386	391	L166P	ProteinMutation	tmVar:p|SUB|L|166|P;HGVS:p.L166P;VariantGroup:0;OriginalGene:57320;CorrespondingGene:11315;RS#:28938172;CorrespondingSpecies:10090;CA#:254090
23657982	402	406	DJ-1	Gene	57320
23657982	486	488	PD	Disease	MESH:D010300
23657982	539	548	Edaravone	Chemical	MESH:D000077553
23657982	563	575	free radical	Chemical	MESH:D005609
23657982	617	641	cerebral ischemic stroke	Disease	MESH:D020521
23657982	696	705	edaravone	Chemical	MESH:D000077553
23657982	713	726	neurotoxicity	Disease	MESH:D020258
23657982	730	732	PD	Disease	MESH:D010300
23657982	753	757	DJ-1	Gene	57320
23657982	782	787	L166P	ProteinMutation	tmVar:p|SUB|L|166|P;HGVS:p.L166P;VariantGroup:0;OriginalGene:57320;CorrespondingGene:11315;RS#:28938172;CorrespondingSpecies:10090;CA#:254090
23657982	816	825	edaravone	Chemical	MESH:D000077553
23657982	928	937	edaravone	Chemical	MESH:D000077553
23657982	971	978	Neuro2a	CellLine	CVCL:0470
23657982	1099	1108	edaravone	Chemical	MESH:D000077553
23657982	1133	1138	VMAT2	Gene	214084
23657982	1153	1156	N2a	CellLine	CVCL:0470
23657982	1265	1274	edaravone	Chemical	MESH:D000077553
23657982	1307	1316	edaravone	Chemical	MESH:D000077553
23657982	1352	1354	PD	Disease	MESH:D010300
23657982	Association	MESH:D010300	RS#:28938172;HGVS:p.L166P;CorrespondingGene:11315
23657982	Negative_Correlation	MESH:D000077553	RS#:28938172;HGVS:p.L166P;CorrespondingGene:11315
23657982	Association	MESH:D020258	RS#:28938172;HGVS:p.L166P;CorrespondingGene:11315
23657982	Association	MESH:D010300	57320
23657982	Negative_Correlation	MESH:D000077553	MESH:D010300
23657982	Negative_Correlation	MESH:D000077553	57320
23657982	Association	MESH:D020258	57320
23657982	Negative_Correlation	MESH:D000077553	MESH:D020521
23657982	Negative_Correlation	MESH:D000077553	MESH:D005609
23657982	Association	MESH:D010302	57320
23657982	Positive_Correlation	MESH:D000077553	214084
23657982	Negative_Correlation	MESH:D000077553	MESH:D020258
23657982	Association	MESH:D010300	11315
23657982	Association	MESH:D020258	11315

